AFC-HD AMS Life Science Co., Ltd. (TYO:2927)

AFC-HD AMS Life Science Revenue

AFC-HD AMS Life Science had revenue of 8.43B JPY in the quarter ending May 31, 2026, with 3.82% growth. This brings the company's revenue in the last twelve months to 33.20B, up 1.90% year-over-year. In the fiscal year ending August 31, 2025, AFC-HD AMS Life Science had annual revenue of 32.66B with 8.18% growth.

• Revenue (ttm): 33.20B
• Revenue Growth: +1.90%
• P/S Ratio: 0.37
• Revenue / Employee: 32.93M
• Employees: 1,008
• Market Cap: 12.43B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2025	32.66B	2.47B	8.18%
Aug 31, 2024	30.19B	4.61B	18.01%
Aug 31, 2023	25.58B	2.58B	11.23%
Aug 31, 2022	23.00B	629.00M	2.81%
Aug 31, 2021	22.37B	6.55B	41.40%

Data Source: S&P Global Market Intelligence Last updated: May 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 20, 2026

Data Sources Report a data error